Sarah Pearson

Sarah is a member of the Investment Committee at Main Sequence, driving investment for early-stage companies linked to the Australian tech sector. Her current VC and asset management portfolio comprises over $50 billion of investment globally, including Funds SA and, previously, the Global Innovation Fund and Impact Investment Exchange Asia. She is a member of the Foreign Investment Review Board, advising the Federal Treasurer on the national interest and national security aspects of proposed foreign investment into Australia.
Sarah’s executive career spans FTSE 100 multinationals, C-suite roles in the public and private sectors, venture capital, academia and startups. She has served as Chancellor of the University of New England, Chief Scientist and Chief Innovation Officer at the Commonwealth Department of Foreign Affairs and Trade, Founding CEO of the CBR Innovation Network, CEO of ANU Enterprise, and Global Head of Open Innovation at Cadbury. She serves on Questacon’s Advisory Council and the Precincts Board, is a director of ANSTO Nuclear Medicine, and is a Fellow of ATSE and the Royal Society of New South Wales. Sarah has invented eight international patents and published in the fields of Particle Physics, Medical Physics, AI and Science Policy.
Sarah holds a DPhil in Particle Physics from the University of Oxford and has completed the AICD Company Directors Course.
Portfolio
Writing
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.